AQR Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

AQR Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$978K	Sell	78,161 -11,401	-13%	-$153K	﹤0.01%	3014
2026 Q1	$1.34M	Buy	89,562 +8,395	+10%	+$187K	﹤0.01%	2616
2025 Q4	$2.03M	Sell	81,167 -14	-0%	-$249	﹤0.01%	2123
2025 Q3	$795K	Sell	81,181 -1,694	-2%	-$10.2K	﹤0.01%	2566
2025 Q2	$353K	Buy	82,875 +37,214	+82%	+$166K	﹤0.01%	2778
2025 Q1	$172K	Buy	+45,661	New	+$230K	﹤0.01%	2921
2024 Q3	–	Sell	-12,125	Closed	-$131K	–	2844
2024 Q2	$131K	Buy	12,125 +704	+6%	+$7.63K	﹤0.01%	2470
2024 Q1	$129K	Buy	11,421 +640	+6%	+$8.26K	﹤0.01%	2313
2023 Q4	$151K	Buy	10,781 +728	+7%	+$9.78K	﹤0.01%	2247
2023 Q3	$124K	Buy	+10,053	New	+$102K	﹤0.01%	2204
2022 Q3	–	Sell	-70,973	Closed	-$289K	–	2280
2022 Q2	$289K	Buy	70,973 +29,457	+71%	+$93.4K	﹤0.01%	1874
2022 Q1	$177K	Buy	+41,516	New	+$229K	﹤0.01%	2086

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

AQR Capital Management's OLMA Position: Q2 2026 in Review

AQR Capital Management reduced its Olema Pharmaceuticals (OLMA) stake by 13% in Q2 2026, selling an estimated $153K and leaving 78,161 shares worth $978K. The position accounts for ﹤0.01% of the portfolio, ranked #3014.

AQR Capital Management first reported a position in OLMA in Q1 2022 and has held it in 12 quarters since. The position peaked at $2.03M in Q4 2025. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

AQR Capital Management held 78,161 shares of Olema Pharmaceuticals worth $978K as of Q2 2026.
AQR Capital Management sold 11,401 Olema Pharmaceuticals shares in Q2 2026, an estimated $153K.
Olema Pharmaceuticals made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #3014 holding.
AQR Capital Management first reported a position in Olema Pharmaceuticals in Q1 2022 and has held it in 12 quarters since.
AQR Capital Management's Olema Pharmaceuticals position peaked at $2.03M in Q4 2025.
186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.